Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 25 November 2021

• Date:
  Thursday, 25 November 2021, All day
• Location:
  Online
  European Medicines Agency, Amsterdam, the Netherlands

This extraordinary meeting is organised to discuss the evaluation of an application to extend the use of Comirnaty, a vaccine for COVID-19 developed by BioNTech and Pfizer, to include children aged 5 to 11.

EMA will communicate on the outcome of the meeting. 

The Committee for Medicinal Products for Human Use (CHMP) is responsible for preparing the European Medicines Agency's opinions on all questions concerning human medicines.